|
|
|
Wednesday, December 9, 2015
|
|
7:30 am - 8:30 am
|
|
|
8:30 am - 8:45 am
|
|
|
8:45 am - 9:30 am
|
Explore Different Models for Managing Oncology Care to
Determine the Best Fit for Your Organization |
After CMS’ introduction of the Oncology Care Model, plans are now deciding whether to apply to pilot the program, adopt aspects of the
model, or wait until more data is available on the structure and benefits of value-based cancer care. Evaluate different models of care to
incorporate value-based care into a health plan oncology management strategy.
- Compare the structures of the Oncology Medical Home, ACOs, and Pathways Programs
- Examine the necessary changes (both internal and external) to adopt value-based payments for oncology
- Recognize key elements of a value-based model for oncology care
|
|
|
Ira Klein, MD, MBA, FACP
Senior Director, Quality, Strategic Customer Group
Janssen Pharmaceuticals
Former Medical Director, Aetna
|
|
|
Lalan Wilfong, MD
Medical Director of Quality Programs
Texas Oncology, PA
|
|
|
|
|
9:30 am - 10:15 am
|
Determine How Payer-Provider Collaborations in the Oncology Market Add Value and Promote Better Risk Management |
When plans and providers collaborate and share data, it is easier to keep track of patient outcomes and manage population health outcomes. Furthermore, the data sharing in these collaborations can better assist both parties in determining how payment structures should be shifted to share financial risks. Hear proven strategies for collaboration that give payers and providers a platform for exchanging key data and learning how to better manage an oncology population.
- Identify strategies for successful collaboration between payers and providers
- Determine how these partnerships help develop an infrastructure for shared risk and the development of alternative payment models
- Understand the importance of data sharing to better manage population health outcomes
- Discuss strategies for how partnerships can shift accountability and payments
|
|
|
Belén Fraile, MD, MSc
Senior Director, Population Health Management, Decision Support & Value Measurement
Dana- Farber Cancer Institute
|
|
|
|
|
10:15 am - 10:45 am
|
|
|
10:45 am - 11:30 am
|
Develop Pathways Partnerships for High Quality Cancer Care |
Cancer therapy that is consistent with nationally recognized guidelines is a fundamental aspect of high quality cancer care, and is a core
requirement of the Oncology Care Model put forth by the Center for Medicare and Medicaid Innovation. By partnering with third party
vendors who help establish treatment pathways, physician practices and health plans can streamline the documentation and reporting
of evidence-based clinical decisions. Hear about one physician-led initiative to implement third-party decision support technology for
medical oncology pathways.
- Gain insight into an oncology practice’s approach to developing a pathways program and selecting a pathway decision support vendor
- Understand how pathways partnerships can improve coordination and quality of care
- Discuss the advantages of payer-provider collaboration in these initiatives under OCM-like reimbursement structures
|
|
|
Aaron Lyss
Director, Value-Based Care
Tennessee Oncology
|
|
|
|
|
11:30 am - 12:15 pm
|
Examine How the CMS Oncology Care Model Can Impact Your Organization |
The Center for Medicare and Medicaid Innovation developed the Oncology Care Model (OCM) and launched a pilot program to try and
shift the way oncology care is managed in order to improve quality and minimize costs. Learn how this model can impact future payment
structures and how the adoption of this model can impact the management of cancer care through the focus of an Integrated Delivery and
Finance System, UPMC and UPMC Health Plan.
- Review the OCM and determine the main components followed in alternative models
- Discuss the cancers and outcomes the CMS Model is looking to evaluate and how these factors are addressed
- Analyze how the OCM will affect future oncology management strategies
|
|
Stephen E. Perkins, MD
Vice President, Medical Affairs
UPMC Health Plan
|
|
|
|
|
12:15 pm - 1:30 pm
|
|
|
1:30 pm - 2:15 pm
|
Develop Feasible Quality Measures for Oncology Care |
It can be difficult to determine outcome measures that are reasonable standards for cancer care. In this session, discuss useful metrics
that can be successful in evaluating the quality of care, and evaluate how certain measures apply to your own organization.
- Discuss outcome metrics that are measurable and specific to oncology
- Evaluate metrics that focus on patient outcomes and perception of care
- Describe data access opportunities and challenges
|
|
|
Kristen McNiff, MPH
Vice President, Quality and Patient Safety
Dana-Farber Cancer Institute
|
|
|
|
|
2:15 pm - 3:00 pm
|
Develop an Integrated Case Management Approach for Patients with Complex Diseases |
When looking at the total cost of care, the top 5% of patients with complex health care conditions will generate up to 50% of the health
care costs. Oncology patients frequently qualify for this category of care needs. Learn how to integrate medical and behavioral health
care management into the conversation with providers and address the patient’s social factors and health system determinants of care in
order to fully address their needs.
- Analyze the value that integrated case management can bring to all stakeholders in managing oncology care
- Identify the basic steps of how to evaluate an integrated approach and incorporate it into practice
- Recognize the benefit from a clinical standpoint as well as the ROI for dedicating resources to an intentional and organized approach
|
|
Peter Dehnel
Medical Director, Integrated Health Management
Blue Cross Blue Shield of Minnesota
|
|
|
|
|
3:00 pm - 3:30 pm
|
|
|
3:30 pm - 4:15 pm
|
CASE STUDY: Develop Collaborative Partnerships to Transform Oncology Care |
When treatment is coordinated and care is streamlined, the quality of care is improved and unnecessary costs can be minimized. Hear
how one plan is establishing a specialty medical home model with network oncologists and working collaboratively to address the health
outcomes, total cost of care, and patient experience related to the treatment of cancer.
- Reduce overall expenditures by incorporating value-based payments
- Engage with quality and cost data to inform ongoing delivery system and payment reform
- Assist with the transformation of cancer care across the attributed population
- Decrease unwarranted variation in practice patterns through the use of evidence-based guidelines
|
|
Shelley Grant
Director, Value Based Initiatives
Capital BlueCross
|
|
Denise F. Harr, MD
Senior Medical Director, Medical Value Initiatives
Capital BlueCross
|
|
|
|
|
4:15 pm - 5:00 pm
|
CASE STUDY: Determine Drug Management Strategies to Alleviate Reliance of
“Living Off the Drug Margin” |
High prices for cancer drugs can impact decisions around treatment and can burden patients with costly hospital bills. Learn how one
plan focused on drug management strategies in order to minimize costs for multiple stakeholders.
- Outline strategies to enhance communication and expedite the prior-authorization process
- Illustrate ways to minimize costs by rewarding oncologists for high-value services and using pathways
- Collaborate with providers to understand side effects and drug costs that influence the choice of treatment regimens
|
|
M. Shawn Stinson, MD, FACP
Chief Medical Officer, Vice President for Clinical Innovation
BlueCross BlueShield of South Carolina
|
|
|
|
|
5:00 pm - 6:00 pm
|
|
|
|
|